October 24, 2020

Market and Financial News Aggregator

AstraZeneca COVID-19 vaccine study paused after one illness

1 min read

Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.

Source link

Leave a Reply